CLINICAL_TRIALS
trial_result
· 2026-03-09
Clinical Trial Update: Daratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma [Phase 2]
Summary
Phase 2 trial evaluating daratumumab in transplant-eligible patients with multiple myeloma has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Plasma Cell Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2026-03-09